VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 665 filers reported holding VANECK VECTORS ETF TR in Q3 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $5,000 | -68.8% | 200 | -52.4% | 0.00% | -50.0% |
| Q1 2022 | $16,000 | +14.3% | 420 | -4.3% | 0.00% | 0.0% |
| Q4 2021 | $14,000 | +7.7% | 439 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $13,000 | -13.3% | 439 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $15,000 | +7.1% | 439 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $14,000 | -12.5% | 439 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $16,000 | -5.9% | 439 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $17,000 | +142.9% | 439 | +119.5% | 0.00% | +100.0% |
| Q2 2020 | $7,000 | +40.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $5,000 | -16.7% | 200 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $6,000 | -50.0% | 200 | -54.2% | 0.00% | -50.0% |
| Q3 2019 | $12,000 | +9.1% | 437 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $11,000 | +175.0% | 437 | +118.5% | 0.00% | +100.0% |
| Q1 2019 | $4,000 | -81.8% | 200 | -79.8% | 0.00% | -75.0% |
| Q1 2018 | $22,000 | – | 988 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |